| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
31,845 |
27,534 |
$8.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
39,260 |
35,021 |
$7.13M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,003 |
9,166 |
$2.77M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
87,204 |
29,629 |
$2.40M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,366 |
11,300 |
$1.69M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,108 |
2,686 |
$1.43M |
| 80053 |
Comprehensive metabolic panel |
19,873 |
16,437 |
$1.36M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,092 |
28,183 |
$992K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,476 |
15,471 |
$925K |
| 84703 |
|
17,704 |
15,464 |
$868K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,086 |
7,235 |
$865K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
23,936 |
18,127 |
$815K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,666 |
12,643 |
$813K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15,404 |
7,935 |
$744K |
| 76801 |
|
2,531 |
1,838 |
$663K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,066 |
1,777 |
$463K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,056 |
746 |
$462K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,065 |
3,533 |
$448K |
| G0378 |
Hospital observation service, per hour |
2,913 |
2,100 |
$437K |
| 36415 |
Collection of venous blood by venipuncture |
39,707 |
30,694 |
$434K |
| 81001 |
|
20,233 |
16,611 |
$383K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,197 |
2,044 |
$370K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,593 |
6,693 |
$354K |
| 80061 |
Lipid panel |
6,356 |
5,637 |
$321K |
| 76830 |
Ultrasound, transvaginal |
1,764 |
1,644 |
$307K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,596 |
6,690 |
$273K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
2,134 |
613 |
$223K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
686 |
648 |
$198K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,717 |
8,453 |
$192K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,922 |
7,214 |
$186K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,094 |
926 |
$181K |
| 71046 |
Radiologic examination, chest; 2 views |
4,991 |
4,435 |
$172K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
544 |
467 |
$164K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,272 |
4,644 |
$164K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,620 |
7,078 |
$164K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
788 |
700 |
$159K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,077 |
843 |
$159K |
| 84484 |
|
12,073 |
8,787 |
$158K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,202 |
5,544 |
$157K |
| 80365 |
|
4,427 |
1,581 |
$151K |
| 80348 |
|
4,249 |
1,581 |
$150K |
| 80076 |
|
3,761 |
3,200 |
$145K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,430 |
1,274 |
$142K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,868 |
4,332 |
$134K |
| 71045 |
Radiologic examination, chest; single view |
7,116 |
6,067 |
$133K |
| 93976 |
|
1,780 |
1,568 |
$129K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,149 |
2,834 |
$118K |
| 84702 |
|
2,275 |
1,638 |
$116K |
| 83690 |
|
8,280 |
6,949 |
$116K |
| 80050 |
General health panel |
956 |
825 |
$115K |
| 83735 |
|
8,607 |
6,736 |
$110K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,745 |
1,893 |
$98K |
| 85027 |
|
12,118 |
8,971 |
$98K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,561 |
1,489 |
$97K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,416 |
1,577 |
$96K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,843 |
1,452 |
$93K |
| 73630 |
|
2,050 |
1,792 |
$90K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,868 |
11,972 |
$88K |
| 86803 |
|
1,567 |
1,330 |
$88K |
| 83605 |
|
4,491 |
3,473 |
$81K |
| 73610 |
|
1,588 |
1,438 |
$80K |
| 93971 |
|
967 |
881 |
$78K |
| 73562 |
|
1,575 |
1,418 |
$77K |
| 86592 |
|
3,889 |
2,991 |
$76K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,323 |
2,876 |
$73K |
| 87340 |
|
2,826 |
1,984 |
$68K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
881 |
712 |
$66K |
| 73030 |
|
1,515 |
1,353 |
$65K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,309 |
2,968 |
$65K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
140 |
124 |
$62K |
| 85610 |
|
10,692 |
8,569 |
$61K |
| 73130 |
|
1,485 |
1,323 |
$58K |
| 85730 |
|
8,465 |
7,007 |
$56K |
| 87040 |
|
2,919 |
1,441 |
$56K |
| 80320 |
|
2,436 |
1,962 |
$55K |
| 81003 |
|
7,092 |
5,885 |
$54K |
| 97803 |
|
1,007 |
966 |
$51K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
588 |
517 |
$51K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,439 |
1,190 |
$49K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,095 |
1,795 |
$46K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,100 |
996 |
$45K |
| 86900 |
|
4,105 |
2,889 |
$43K |
| 70486 |
|
539 |
473 |
$42K |
| 85379 |
|
2,524 |
2,233 |
$41K |
| 80074 |
|
441 |
296 |
$41K |
| 85007 |
|
5,613 |
4,671 |
$38K |
| 82043 |
|
778 |
695 |
$38K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,772 |
680 |
$37K |
| 87186 |
|
1,896 |
1,613 |
$37K |
| 86901 |
|
4,105 |
2,892 |
$36K |
| 84439 |
|
1,105 |
911 |
$34K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,661 |
1,474 |
$33K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,773 |
3,115 |
$33K |
| 82728 |
|
1,246 |
1,065 |
$33K |
| 83880 |
|
1,744 |
1,517 |
$33K |
| 73560 |
|
1,351 |
1,187 |
$32K |
| 73565 |
|
1,216 |
1,082 |
$32K |
| 73110 |
|
839 |
744 |
$32K |
| 76642 |
|
185 |
172 |
$31K |
| 93970 |
|
289 |
263 |
$28K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
229 |
80 |
$28K |
| 86850 |
|
3,644 |
2,501 |
$28K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
2,483 |
1,874 |
$26K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
995 |
675 |
$26K |
| 82950 |
|
1,063 |
790 |
$26K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
94 |
90 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
183 |
168 |
$24K |
| 10060 |
|
542 |
508 |
$24K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,081 |
13,467 |
$24K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,623 |
1,953 |
$22K |
| A0425 |
Ground mileage, per statute mile |
89,123 |
30,643 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,889 |
1,832 |
$21K |
| 72110 |
|
548 |
494 |
$20K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
172 |
92 |
$20K |
| 82550 |
|
3,388 |
2,763 |
$19K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,375 |
1,311 |
$19K |
| 71250 |
|
241 |
202 |
$19K |
| 87081 |
|
1,211 |
1,109 |
$18K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
652 |
510 |
$18K |
| 94644 |
|
759 |
645 |
$17K |
| 87070 |
|
1,010 |
805 |
$16K |
| 84460 |
|
649 |
521 |
$15K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
122 |
107 |
$15K |
| 96376 |
|
1,285 |
981 |
$15K |
| 83540 |
|
1,113 |
949 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
344 |
288 |
$14K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
183 |
136 |
$13K |
| 73502 |
|
806 |
730 |
$12K |
| 97597 |
|
326 |
158 |
$12K |
| 84450 |
|
461 |
427 |
$11K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
732 |
650 |
$11K |
| 87077 |
|
138 |
116 |
$11K |
| 87481 |
|
430 |
392 |
$11K |
| 84466 |
|
1,023 |
870 |
$10K |
| 87512 |
|
430 |
392 |
$10K |
| 86762 |
|
1,488 |
831 |
$9K |
| 82248 |
|
255 |
210 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,507 |
6,612 |
$9K |
| 80069 |
|
427 |
372 |
$9K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,874 |
1,970 |
$9K |
| 90714 |
|
1,014 |
940 |
$8K |
| 80081 |
|
490 |
385 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,005 |
921 |
$8K |
| 82607 |
|
602 |
469 |
$8K |
| 82947 |
|
329 |
322 |
$8K |
| 72131 |
|
13 |
12 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
903 |
289 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
524 |
420 |
$7K |
| 93017 |
|
102 |
93 |
$7K |
| 82553 |
|
1,456 |
1,162 |
$7K |
| 88342 |
|
424 |
347 |
$6K |
| 87147 |
|
637 |
551 |
$6K |
| 82570 |
|
677 |
547 |
$6K |
| 97010 |
|
2,465 |
639 |
$6K |
| 86141 |
|
709 |
564 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,139 |
2,532 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,516 |
1,364 |
$5K |
| 97162 |
|
275 |
246 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,287 |
1,145 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
4,564 |
2,920 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,386 |
1,940 |
$5K |
| 87205 |
|
1,085 |
735 |
$4K |
| 72100 |
|
261 |
236 |
$4K |
| 85651 |
|
912 |
657 |
$4K |
| A0380 |
Bls mileage (per mile) |
1,610 |
1,147 |
$4K |
| 93975 |
|
81 |
70 |
$4K |
| 73080 |
|
119 |
106 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
424 |
364 |
$3K |
| 62323 |
|
16 |
12 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,563 |
2,175 |
$3K |
| 12001 |
|
124 |
118 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
12 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
37 |
24 |
$3K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
186 |
106 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
1,196 |
839 |
$2K |
| 84480 |
|
71 |
57 |
$2K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
30 |
26 |
$2K |
| 83655 |
|
169 |
152 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,786 |
1,377 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,400 |
613 |
$2K |
| 97802 |
|
29 |
29 |
$2K |
| 94760 |
|
1,406 |
675 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
68 |
65 |
$2K |
| 80362 |
|
17 |
13 |
$2K |
| 76536 |
|
44 |
38 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,155 |
1,830 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
912 |
495 |
$2K |
| 96367 |
|
492 |
133 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
308 |
264 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
682 |
518 |
$1K |
| 83021 |
|
409 |
179 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,642 |
986 |
$1K |
| 83615 |
|
101 |
74 |
$991.95 |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
220 |
199 |
$952.28 |
| 83020 |
|
18 |
13 |
$897.59 |
| J1815 |
Injection, insulin, per 5 units |
850 |
348 |
$874.55 |
| J1630 |
Injection, haloperidol, up to 5 mg |
781 |
615 |
$865.37 |
| 84100 |
|
274 |
189 |
$861.58 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
71 |
67 |
$843.80 |
| 97161 |
|
74 |
55 |
$828.60 |
| 86038 |
|
42 |
29 |
$818.36 |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
42 |
40 |
$779.49 |
| 76819 |
Fetal biophysical profile; without non-stress testing |
396 |
180 |
$728.85 |
| 82746 |
|
110 |
94 |
$710.55 |
| 87480 |
|
34 |
26 |
$675.70 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
58 |
49 |
$669.03 |
| 82652 |
|
60 |
59 |
$642.72 |
| 87660 |
|
34 |
26 |
$640.69 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
210 |
94 |
$628.50 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
82 |
67 |
$622.40 |
| 87510 |
|
33 |
25 |
$618.27 |
| A9270 |
Non-covered item or service |
795 |
663 |
$618.17 |
| 29125 |
|
29 |
27 |
$612.30 |
| 84156 |
|
122 |
101 |
$604.00 |
| C1769 |
Guide wire |
393 |
136 |
$525.71 |
| J1644 |
Injection, heparin sodium, per 1000 units |
761 |
239 |
$488.86 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
56 |
17 |
$464.72 |
| 88304 |
|
85 |
62 |
$447.37 |
| 29515 |
|
14 |
12 |
$437.06 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,297 |
385 |
$431.36 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,543 |
1,060 |
$426.85 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
324 |
191 |
$410.68 |
| 84550 |
|
111 |
24 |
$399.24 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
277 |
199 |
$334.28 |
| 85018 |
|
40 |
38 |
$299.18 |
| 82105 |
|
15 |
13 |
$260.83 |
| 87535 |
|
92 |
81 |
$231.28 |
| 87400 |
|
162 |
129 |
$211.14 |
| 85014 |
|
40 |
38 |
$201.94 |
| 76813 |
|
95 |
13 |
$200.85 |
| 73590 |
|
64 |
55 |
$191.35 |
| 97804 |
|
13 |
13 |
$187.68 |
| 88307 |
|
16 |
13 |
$169.52 |
| 0011A |
|
43 |
24 |
$156.80 |
| 88141 |
|
125 |
116 |
$149.82 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
26 |
24 |
$147.79 |
| J3480 |
Injection, potassium chloride, per 2 meq |
29 |
15 |
$146.07 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
587 |
363 |
$132.95 |
| 84146 |
|
18 |
13 |
$119.23 |
| 0012A |
|
50 |
26 |
$111.30 |
| 82565 |
|
188 |
162 |
$106.43 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,991 |
1,757 |
$95.24 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
67 |
42 |
$94.72 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
41 |
28 |
$69.39 |
| 96415 |
|
102 |
13 |
$65.80 |
| 85045 |
|
199 |
165 |
$62.52 |
| 73140 |
|
101 |
91 |
$51.12 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
1,424 |
1,259 |
$26.95 |
| 82247 |
|
17 |
12 |
$24.28 |
| 95886 |
|
60 |
53 |
$15.90 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
49 |
40 |
$15.58 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
36 |
25 |
$12.20 |
| 81002 |
|
112 |
92 |
$11.14 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
52 |
38 |
$6.26 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
41 |
37 |
$5.48 |
| 82977 |
|
14 |
13 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
33 |
25 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
51 |
38 |
$0.00 |
| 84520 |
|
36 |
36 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
51 |
27 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
15 |
12 |
$0.00 |
| 85008 |
|
80 |
66 |
$0.00 |
| 80329 |
|
13 |
13 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
50 |
38 |
$0.00 |
| 82951 |
|
32 |
29 |
$0.00 |
| A0434 |
Specialty care transport (sct) |
68 |
13 |
$0.00 |